TESAMORELIN (5mg)

A$69.99

Tesamorelin is a high-purity, COA-verified research peptide supplied as a lyophilised powder for laboratory research applications. Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) and has been extensively studied in research settings for its role in endocrine and metabolic signalling pathways.

Due to its targeted interaction with growth hormone release mechanisms, Tesamorelin is commonly referenced in studies focused on body composition and metabolic regulation.

What Tesamorelin Is Studied For

In laboratory and preclinical research environments, Tesamorelin has been investigated for its involvement in:

  • Growth hormone release and regulation pathways

  • Reduction of visceral adipose tissue in metabolic research models

  • Insulin-like growth factor (IGF-1) signalling mechanisms

  • Body composition and lipid metabolism studies

  • Neuroendocrine feedback and regulation

These findings are based on research models only and do not imply therapeutic or approved medical use.

Product Details

  • Form: Lyophilised powder

  • Purity: ≥ 99% (HPLC verified)

  • Verification: Certificate of Analysis (COA) provided

  • Structure: Synthetic GHRH analogue

  • Grade: Research use only

Storage & Handling

  • Store at 2–8°C or as specified on the COA

  • Protect from light and moisture

  • Avoid repeated freeze–thaw cycles

  • Handle using appropriate laboratory safety and aseptic procedures

Important Notice

This product is supplied for laboratory research use only.
Not for human or veterinary consumption.
Not intended to diagnose, treat, cure, or prevent any disease.

Tesamorelin is a high-purity, COA-verified research peptide supplied as a lyophilised powder for laboratory research applications. Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) and has been extensively studied in research settings for its role in endocrine and metabolic signalling pathways.

Due to its targeted interaction with growth hormone release mechanisms, Tesamorelin is commonly referenced in studies focused on body composition and metabolic regulation.

What Tesamorelin Is Studied For

In laboratory and preclinical research environments, Tesamorelin has been investigated for its involvement in:

  • Growth hormone release and regulation pathways

  • Reduction of visceral adipose tissue in metabolic research models

  • Insulin-like growth factor (IGF-1) signalling mechanisms

  • Body composition and lipid metabolism studies

  • Neuroendocrine feedback and regulation

These findings are based on research models only and do not imply therapeutic or approved medical use.

Product Details

  • Form: Lyophilised powder

  • Purity: ≥ 99% (HPLC verified)

  • Verification: Certificate of Analysis (COA) provided

  • Structure: Synthetic GHRH analogue

  • Grade: Research use only

Storage & Handling

  • Store at 2–8°C or as specified on the COA

  • Protect from light and moisture

  • Avoid repeated freeze–thaw cycles

  • Handle using appropriate laboratory safety and aseptic procedures

Important Notice

This product is supplied for laboratory research use only.
Not for human or veterinary consumption.
Not intended to diagnose, treat, cure, or prevent any disease.